rs387907008
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_ModeratePP5_Moderate
The NM_005461.5(MAFB):c.212C>T(p.Pro71Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P71S) has been classified as Pathogenic.
Frequency
Consequence
NM_005461.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAFB | NM_005461.5 | c.212C>T | p.Pro71Leu | missense_variant | 1/1 | ENST00000373313.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAFB | ENST00000373313.3 | c.212C>T | p.Pro71Leu | missense_variant | 1/1 | NM_005461.5 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Multicentric carpo-tarsal osteolysis with or without nephropathy Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 09, 2012 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | May 07, 2020 | The MAFB c.212C>T (p.Pro71Leu) variant is a missense variant and has been reported in at least two individuals in a de novo heterozygous state. Both individuals presented with skeletal anomalies characteristic of multicentric carpotarsal osteolysis syndrome, with one individual also presenting with renal disease (Zankl et al. 2012; Park et al. 2018). While there are no functional studies for this variant, it is located in the amino-terminal transcriptional activation domain where all clinically significant variants identified to date are located, specifically across residues 54-71. In addition, different amino acid changes at the Pro71 residue have been reported in affected individuals (Zankl et al. 2012; Mumm et al. 2014). The p.Pro71Leu variant was absent from 164 control individuals (Zankl et al. 2012) and is not reported in the Genome Aggregation Database in a region of good sequence coverage so the variant is presumed to be rare. Based on the collective evidence, the p.Pro71Leu variant is classified as pathogenic for multicentric carpotarsal osteolysis syndrome. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at